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Abstract
Background: The γ-secretase complex, composed of transmembrane proteins termed presenilin (PS), anterior pharynx
defective (APH), nicastrin (NCT), and presenilin enhancer-2 (Pen-2) catalyzes intramembranous hydrolysis of a variety of
Type I membrane protein substrates. In order to understand aspects of subunit assembly, interactions, dynamics and
catalysis, it is essential to clarify the membrane topology of each polypeptide. Hydophathicity plots predict that the 101
amino acid Pen-2 molecule has two hydrophobic domains (HP1 and HP2) that may serve as transmembrane spanning
domains. Earlier reports indicated that transiently overexpressed Pen-2 uses these two hydrophobic domains as
transmembrane helices that generates a “U-shaped” hairpin topology with both amino- (N-) and carboxyl-(C-) termini
facing the lumen. In this report, we have reexamined the topology of endogenous Pen-2 and Pen-2 chimeras that are
stably expressed in mammalian cells, and have assessed the function of these molecules in rescuing γ-secretase activity
in Pen-2-deficient fibroblasts.
Results: We confirm that the Pen-2 C-terminus is lumenal, but the N-terminus of Pen-2 is exposed to the cytoplasm,
thus indicating that HP1 does not traverse the lipid bilayer as a transmembrane domain. Domain swapping studies
reveal the importance of specific regions within the first hydrophobic domain of Pen-2 that are critical for generating
the topology that is a prerequisite for mediating PS1 endoproteolysis and γ-secretase activity. Finally, we report that
the first fourteen amino acids of the Pen-2 HP1 are required for γ-secretase activity.
Conclusions: We propose that the first hydrophobic domain of Pen-2 forms a structure similar to a reentrant loop
while the second hydrophobic domain spans the lipid bilayer.
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Background
The γ-secretase complex catalyzes intramembranous pro-
teolysis of several type I membrane proteins, including the
amyloid-beta precursor protein (APP) and Notch (for
review, see Ref.[1]) and is composed of presenilins (PS1
and PS2), anterior pharynx defective (APH-1), and prese-
nilin enhancer-2 (Pen-2) and the Type I membrane pro-
tein, nicastrin (NCT) [2–4]. During the assembly of active
γ-secretase, Aph-1 and NCT form a stable subcomplex
that binds to, and stabilizes the PS holoprotein/zymogen
[5, 6] via binding to the PS1 C-terminus [7]. Pen-2 then
binds to PS1 in the trimeric APH-1-NCT-PS1 complex,
and promotes the proteolytic conversion of the PS holo-
protein into ~37-40 kDa N- and ~17-20 kDa C-terminal
fragments that are the preponderant PS1 polypeptides that
accumulate in vivo [5, 6, 8–13]. The steady-state levels of
each subunit of the γ-secretase complex is coordinately
regulated and dependent on the expression of other com-
ponents of the complex [14].
The topology of PS1 [15] and Aph-1 [16] have been
determined. Hydopathicity plots of Pen-2 indicate the
presence of two hydrophobic regions (HP1 and HP2) that
could serve as potential transmembrane domains (TMD)
[2]. We reported that the proximal two-thirds of the Pen-
2 HP1 is functionally required for endoproteolysis of PS1
holoproteins and the generation of PS1 fragments, while
the C-terminal hydrophilic domain of Pen-2 is critical for
* Correspondence: ssisodia@bsd.uchicago.edu
†Equal contributors
1Department of Neurobiology, The University of Chicago, 947 E. 58th St.
MC0928, Chicago Il 60637, USA
Full list of author information is available at the end of the article
© 2015 Zhang et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Zhang et al. Molecular Neurodegeneration  (2015) 10:39 
DOI 10.1186/s13024-015-0037-4
stabilizing the PS1 NTF- and CTF, but is not required for
PS1 endoproteolysis [17]. In this regard, it has been
reported that Pen-2 assumes a “U-shaped” hairpin top-
ology wherein the HP regions serve as TMDs and both
the N- and C-terminal domains are exposed to the lumen
[18, 19].These conclusions were based on analysis of Pen-
2 chimeras with engineered N-glycosylation sites that
were transiently expressed in mammalian cells. Three
complementary approaches were employed: examination
of N- glycosylation site usage to demonstrate lumenal ex-
posure, immunofluorescence detection by selective mem-
brane permeabilization agents (Streptolysin O (SLO) or
Triton X-100), and protease protection assays. Similarly,
we reported that proteinase K treatment of membranes
prepared from HEK293 cells transiently cotransfected
with cDNA encoding PS1, NCT, APH-1 and Pen-2
resulted in the protection of ~6 kDa carboxyl- (CTF) and
~4 kDa amino-terminal (NTF) fragments derived from
Pen-2, suggesting that the molecule adopts a “U-shaped”
hairpin topology [17]. Unfortunately, there are several
experimental caveats that would lead to misinterpretation
of the outcomes reported by Crystal et al. [18] and
Bergman et al. [19], the most significant of which is
that the functional activity of the overexpressed Pen-2
variants in mediating PS1 endoproteolysis or γ-secretase
activity were never assessed. Furthermore, the fact that
steady-state accumulation of each component of the γ-
secretase complex is strictly regulated by the levels of
other subunits [14], transient overexpression would lead
to unproductive populations of unassociated subunits that
are likely to be misfolded and hence, could adopt alternate
topologies, or differential membrane insertion characteris-
tics. In this regard, we reported that while detectable levels
of Pen-2 NTF and CTF were protected from proteinase K
digestion of membranes from HEK293 cells that transi-
ently coexpressed PS1, NCT, APH-1 and Pen-2, the levels
of these fragments were extremely low. Instead, the bulk
of Pen-2 remained as full-length molecules even up to 25
ug/ml of enzyme. Moreover, solubilization of this mem-
brane preparation by the addition of Triton-X100, prior to
the addition of 25 ug/ml proteinase K, completely elimi-
nated the full-length Pen-2 signal [17], a finding that
would suggest that the vast majority of Pen-2 expressed in
this overexpression setting was lumenally disposed, a sce-
nario that we consider highly unlikely. Thus, we felt it was
important to investigate the topology of endogenous Pen-
2 or Pen-2 that are stably expressed in mammalian cells.
In the present report, we confirm that the C-terminus of
Pen-2 is lumenally disposed, but in contrast to earlier
studies, we document that the N-terminus resides in the
cytoplasm. Furthermore, we demonstrate that a subregion
within HP1 is critical for determining the topology of Pen-
2 that is required for facilitating PS1 endoproteolysis and
γ-secretase activity [17].
Results and discussion
Pen-2 does not exhibit a “U-shaped” hairpin topology
Standard hydropathicity plots reveal that Pen-2 harbors
two hydrophobic regions (HP1 and HP2) separated by a
21 amino acid spacer. When expressed in transiently
transfected cells, it has been reported that Pen-2 adopts
a “U-shaped” hairpin topology with both N- and C-
termini facing the membrane lumen [17–19]. In view of
the possibility that transiently overexpressed membrane
proteins may adopt multiple protein conformations and
topologies, we reexamined Pen-2 topology in HEK293
cells that express Pen-2 endogenously or in N2aWT.11
cells [8] that stably express wild-type human Pen-2 har-
boring a C-terminal CT-11 epitope tag [17]. We pre-
pared 15,000 x g (P15) membrane fractions from these
cells, and treated the material with proteinase K in the
absence or presence of 1 % Triton X-100. The reaction
products were analyzed by SDS-PAGE and Western blot
analysis with the CT11 antibody or the PNT-2 antibody
generated against the first 26 residues of PEN-2 [11].
Proteinase K treatment of the membrane fractions from
N2aWT.11/Pen-2 cells lead to an ~5 kDa CT11-positive
C-terminal fragment (CTF) that was protected from di-
gestion (Figure 1a, lane 5), while co-incubation of a par-
allel mixture with Proteinase K together with Triton X-
100, a detergent that disrupts all membranes, eliminated
this fragment (Fig. 1a, lane 6). These results indicate that
in N2aWT.11 cells expressing CT11-tagged Pen-2, the
CT11 epitope resides in the lumen, a result consistent
with earlier findings [18]. Unfortunately, an antibody
specific for the native Pen-2 C-terminus is not available,
and hence, the disposition of Pen-2 expressed endogen-
ously in HEK293 could not be determined. We then
probed Western blots of protease-treated membranes
with the PNT-2 antibody (Fig. 1b). In protease-treated
HEK293 membranes (Fig. 1b, lane 2) or N2aWT.11/Pen-
2 membranes (Fig. 1b, lane 5), we observe that the full-
length Pen-2 signal is eliminated, but surprisingly, we
failed to detect the predicted 4-kDa amino-terminal frag-
ment (NTF) that would have been protected if this region
faced the lumen. This result suggests that the amino-
terminus of Pen-2 is sensitive to the proteinase K, arguing
that the epitope(s) detected by PNT-2 are located in the
cytoplasm. In summary, these latter studies do not sup-
port the “U-shaped” topology model that was proposed
earlier, and argue instead for a model in which the Pen-
2 N-terminus is cytosolic and the C-terminus is lumenal.
The results presented above would suggest that Pen-2
must adopt a topology consistent with an odd (either one
or three) number of TMDs. If HP1 was utilized as the sole
TMD, then we would have expected an ~10 kDa C-
terminal, CT11-positive protected fragment after protease
treatment of N2aWT.11/Pen-2 membranes. However, our
demonstration that an ~5 kDa protected CTF is observed
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in protease-treated N2aWT.11/Pen-2 membranes can
only be consistent with HP2 serving as the sole TMD.
In earlier studies, we examined the function of a CT11
epitope-tagged Pen-2 chimera, TMD2-SREBPPen-2, in
which the Pen-2 HP2 was replaced with the first TMD of
the sterol regulatory binding element binding protein-1
(SREBP). SREBP exhibits a “bell-shaped” hairpin topology,
and hence we chose to replace Pen-2 HP2 with the TMD1
of SREBP in order to maintain the native Type I mem-
brane orientation. We demonstrated that this chimeric
molecule retains Pen-2 function in mediating endoproteo-
lysis of PS1 and γ-secretase activity [17] and hence, the
amino acid sequence of HP2 perse was not a functional
determinant. Because the first HP region of SREBP is a
bona fide TMD, it follows that HP2 of Pen-2 is likely to be
a TMD, as well, a conclusion supported by the protection
of a CT11-positive ~5 kDa CTF after protease digestion of
membranes from N2aWT.11/Pen-2 cells. Taken together
with the results shown in Fig. 1, which revealed that the
N-terminus is sensitive to protease digestion, we felt it
was implausible that the Pen-2 HP1 region could also
serve as a TMD. Nevertheless, we tested the possibility
that the Pen-2 HP1 could serve as a TMD, as was previ-
ously reported [17–19] by generating a stable cell line
expressing “TMD1”, a SREBP/Pen-2 chimera in which
HP1 of Pen-2 was replaced with TMD2 of SREBP that has
a Type II membrane orientation (Fig. 2a). We had previ-
ously established that this fusion protein is not functional
with respect to promoting PS1 endoproteolysis or γ-
secretase activity [17]. Moreover, this fusion protein does
not coimmunoprecipitate with PS1 [17], a result which
indicated that the Pen-2 HP1 mediates binding to PS1. To
determine the topology of TMD1, we prepared mem-
branes from an N2aWT.11 cells that stably expresses this
chimera, then treated this preparation with proteinase K
and performed Western blot assays with PNT-2 or CT11
antibodies. We neither detected protected NTF derived
from wild-type Pen-2, as expected, nor from the TMD1
chimera, indicating that the N-termini of these molecules
are cytoplasmic (Fig. 2b, upper panel, lanes 2 and 5,
respectively). In contrast, while proteinase K generated a
protected ~5 kDa CT11-positive CTF derived from wild-
type Pen-2 (Fig. 2b, lower panel, lane 2), we did not
observe a protected CTF derived from the TMD1 chimera
(Fig. 2b, lower panel, lane 5). We interpret this result to
suggest that replacement of the Pen-2 HP1 with the
authentic TMD2 of SREBP now generates a chimera with
2 TMDs wherein both the N- and C-termini face the cyto-
plasm and that the 21 amino acid spacer separating the
TMDs that would otherwise reside in the cytosol would
now be recruited into the lumen. As a consequence, in the
TMD1 chimera, the Pen-2 HP2 would be forced to span
the membrane in a Type II orientation that is opposite
from that predicted for native Pen-2, thus resulting in a
“bell-shaped” hairpin topology, similar to the membrane
topology of SREBP and depicted in Fig. 2, Model E. This
drastic change of topology also explains the loss of func-
tion for the TMD1 chimera [17]. While this model is
satisfying, the membrane disposition of the Pen-2 HP1
remained uncertain.
Molecular features of the pen-2 HP1
Since the TMD2-SREBPPen-2 chimera was functional,
thus arguing that the sequence of the Pen-2 HP2 was dis-
pensable for function [17], we reasoned that the sequence
of HP1 must confer function to Pen-2. Indeed, we had
demonstrated that the Pen-2 HP1 is necessary for inter-
acting with PS1 [17]. In order to examine the topology of
the Pen-2 HP1, we designed a strategy to rescue the activ-
ity of the functionally inactive CT11 epitope-tagged
TMD1 chimera (14). To this end, we replaced single or
multiple seven amino acid segments of the SREBP TMD2
with analogous segments of the Pen-2 HP1[17] (Fig. 2a).
We showed that the only chimera to fully rescue PS1
Fig. 1 The amino-terminus of Pen-2 is in the cytoplasm and the carboxyl-terminus is in the lumen. 10 μg of protein from P15 fractions from HEK
293 cells (Lanes 1–3) or stable N2aWT.11 cells expressing CT11-tagged Pen-2 (Lanes 4–6) were incubated with Proteinase K in the absence or
presence of Triton X-100. Resulting reactions were fractionated in 16.5 % Tris/Tricine SDS-PAGE and analyzed by Western blotting with CT11 (a.
Lanes 1–6) or PNT-2 (b. Lanes 1–6) antibodies. Molecular mass markers are shown on the left in kilodaltons
Zhang et al. Molecular Neurodegeneration  (2015) 10:39 Page 3 of 8
endoproteolysis and γ-secretase activity was PPS (P = Pen-
2; S = SREBP), in which the first fourteen amino acids of
SREBP TMD2 was replaced with the first fourteen amino
acids of Pen-2 HP1[17].
We sought to determine the topology of the functional
PPS chimera or two functionally inactive chimeras,
termed SPP and PSP [17] as a surrogate assay for func-
tionality. We prepared membranes from N2a cells that
stably express CT11 epitope-tagged PPS, SPP and PSP
chimeras, then treated the membranes with proteinase K
and subject resulting products to Western blot analysis.
Using PNT-2 antibody, we show that the N-terminal
epitope(s) in all three chimeras are sensitive to proteolysis,
as a protected NTF was undetectable (Fig. 2c, top panel,
lanes 2, 5, 8). Thus, the N-termini of these molecules must
face the cytoplasm. Interestingly, like wild-type Pen-2
(Fig. 2b, lane 2), an ~5 kDa CT11-positive CTF was also
protected in membranes expressing the SPP and PPS
chimeras (Fig. 2c, bottom panel, lanes 2 and 8, respect-
ively), indicating that the C-termini of these two proteins
face the lumen. However, we did not observe a protected
CTF derived from PSP (Fig. 2c, bottom panel, lane 5), sug-
gesting that this region is protease-sensitive, and hence,
must face the cytoplasm. We suggest that in the PSP
chimera, the hybrid HP1 behaves as a true TMD that
spans the membrane, thus resulting in a topology similar
to the TMD1chimera or SREBP, itself, that exhibit a “bell-
shaped” hairpin topology (Fig. 2, Model E). This hairpin
topology model of PSP may explain the inability of this
chimera to rescue the loss of function observed for the
TMD1chimera [17].
Our earlier demonstration that the PPS chimera was
functional with respect to PS1 endoproteolysis and γ-
secretase activity [17], while the SPP and PSP were not,
left unresolved the importance of the domain(s) within
the first fourteen amino acids on the Pen-2 HP1 that are
Fig. 2 The first hydrophobic region of Pen-2 is not a TMD. a. Sequence of Pen-2 HP1, SREBP TMD2 and Pen-2-SREBP chimeras. b. Cell membranes
from stable cell lines expressing CT11 tagged Pen-2 (lanes 1–3) or Pen-2 TMD1 chimera (lanes 4–6) were treated with proteinase K in the absence
or presence of Triton X-100 and resulting products were subject to immunoblotting with PNT2 (upper panel) or CT11 (lower panel) antibodies. c.
Cell membranes from Pen-2 chimeras with substitutions of segments from the SREBP TMD2 were treated with proteinase K in the absence or
presence of Triton X-100 and resulting products were subject to immunoblotting with PNT2 (upper panel) or CT11 (lower panel) antibodies.
Molecular mass markers are shown on the left in kilodaltons. d. Pen-2 model proposed in Refs 17, 18 and 19. E. Model for Pen-2 TMD1. F. Revised
Pen-2 model
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responsible for function. We sought to establish the im-
portance of this region by asking whether we could rescue
γ-secretase activity in cells that lack expression of Pen-2.
For these studies, we obtained Pen-2-deficient fibroblasts
that exhibit no detectable γ-secretase activity and in which
the trimeric APH-1-NCT-PS1 intermediate complex is
readily observed by Blue Native (BN)-PAGE analysis [20].
We transiently cotransfected Pen-2-deficient fibroblasts
with cDNA encoding a well-established γ-secretase sub-
strate, termed mouse Notch 1 lacking the ECD segment
(mNΔE) [21] and cDNAs encoding wild-type Pen-2, SPP,
PSP, PPS or TMD1 (Fig. 3a). We observe that NICD is not
produced in Pen-2 deficient fibroblasts transfected with
the parental vector of the Pen-2 constructs (Fig. 3a, lane
1), but that expression of wild-type Pen-2 and PPS rescued
NICD production (Fig. 3a, lanes 2, 5 respectively), while
the SPP, PSP and TMD1 chimeras did not (Fig. 3a, lanes
3, 4 and 6, respectively). To establish that these latter
results could be extended to another γ-secretase substrate,
we transiently cotransfected Pen-2-deficient fibroblasts
with cDNA encoding the FAD-linked APP “Swedish”
variant (APPswe) together with cDNAs encoding wild-
type Pen-2, SPP, PSP, PPS or TMD1 (Fig. 3b). As expected,
high levels of APP-CTFs were observed in cells trans-
fected with cDNA encoding APPswe and parental (empty)
vector (Fig. 3b, lane 1); notably, the α-CTF derivatives are
generated primarily from endogenous APP and to a lesser
degree from APPswe, while the β-CTF is derived primarily
from APPswe that must be present only in the small
fraction of fibroblasts that were transiently transfected.
We observed a significant reduction of β-CTF levels by
expression of wild-type Pen-2 and the PPS chimera
(Fig. 3b, lanes 2, 5 respectively), while expression of the
SPP, PSP and TMD1 chimeras failed to do so (Fig. 3b,
lanes 3, 4 and 6, respectively). The reduction in levels of
β-CTF by expression of wild-type Pen-2 or the PPS
chimera support the view that γ-secretase activity is
elevated in cells that express these polypeptides. In sum-
mary, these functional assays in transiently transfected Pen-
2-deficient fibroblasts fully support our earlier functional
studies in HEK293 cells transiently transfected with PS1,
APH-1, NCTand Pen-2 or the Pen-2-SREBP chimeras [17].
More importantly, it is quite clear that separation of the
first seven amino acids and the middle seven amino acids
of HP1 of Pen-2 by an intervening segment is functionally
intolerant, but that these regions need to be in contiguity
(as in PPS) in order to restore function.
Conclusions
Defining the topology, molecular interactions and dynam-
ics of the putative transmembrane helices of PS, Aph-1
and Pen-2 are critical for understanding the assembly and
mechanism(s) underlying the catalytic activity of γ-
secretase. While the topology of PS1 and APH-1 have been
established, the reported topology of Pen-2 existing as a
“U-shaped” hairpin was equivocal because the exogenous
proteins being examined were transiently overexpressed
[17–19], conditions that may lead to the production of
misfolded polypeptides with multiple topologies, mixed
membrane insertion properties and subunit interactions.
We sought to eliminate these potential artefacts by exam-
ining the topology of Pen-2 expressed endogenously, or in
cell lines that stably express Pen-2 or a panel of Pen-2
chimeras and we now offer several important insights.
First, we show that Pen-2 expressed endogenously or in
stable cell lines does not adopt a “U-shaped” hairpin, as
was described earlier [17–19] .Using proteinase K protec-
tion assays, we confirm that the C-terminus faces the
lumen, but that the N-terminus is sensitive to proteolysis,
thus indicating that this region faces the cytoplasm. Not-
ably, we attempted to validate this conclusion using
detergents that selectively permeabilize plasma and/or
intracellular membranes combined with immunofluores-
cence approaches using the N-terminal-specific PNT-2
antibody, but failed to detect the epitope (data not shown),
thus arguing that this domain is buried. This finding is
fully consistent with studies from our own laboratory [17]
and others [19, 22] showing that antibodies specific for
the amino-terminal region of Pen-2 fail to coimmunopre-
cipitate PS1-NTF and components of the γ-secretase
Fig. 3 Rescue of γ-secretase Function in Pen-2-deficient fibroblasts by Pen-2 and the PPS chimera. a. mNΔE Processing in transiently cotransfected
cells. b. APPswe processing in transiently cotransfected cells
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complex from membranes solubilized with mild detergents
including DDM or CHAPSO. These findings received fur-
ther support from chemical accessibility labeling studies
which revealed that a large and charged sulfhydryl-specific
reagent failed to modify experimentally introduced cysteine
residues in this region [20].
Second, we demonstrate that a stably expressed Pen-2
chimera, TMD1, in which the Pen-2 HP1 is replaced by
TMD2 of SREBP, exhibits a “U-shaped” hairpin structure
which is most likely the reason that this chimera is
functionally inactive in mediating PS1 endoproteolysis and
γ-secretase activity. Third, we examined the topology of a
panel of stably expressed Pen-2-SREBP chimeras wherein
short segments of the SREBP TMD2 were replaced with
analogous peptides from the Pen-2 HP1. In view of the
fact that the PPS chimera was functional, while the PSP
chimera was not, we speculate that the peptide sequence
in the middle third of the Pen-2 HP1, FLPFLWL, must
play a critical role in insuring that Pen-2 adopts the
correct topology. Indeed, comparison of this region of hu-
man Pen-2 and the analogous region from Pen-2 in phylo-
genetically divergent species, including M. musculus, D.
rario (zebrafish), D. melanogaster and C. elegans reveals
that the “FLP F/L V/L/ W” peptide sequence is highly
conserved, and it is likely that the presence of the proline
residue (Pro27) in the center of HP1 would act to “kink”
the α-helix [23]. Interestingly, Bammens et al. [20] have
shown that the Pen-2 P27C mutant accumulated to very
low levels when stably expressed in Pen-2-deficient cells
that also correlated with low levels of γ-secretase complex
levels. Since proline residues have a restricted backbone
that can significantly affect protein structure, we would
argue that this residue has an impact both on the stability
of Pen-2 and the γ-secretase complex. While plausible,
our conclusion that P27 and the central region of the Pen-
2 HP1 is required for function is tempered by the fact that
SPP, a chimera with topological similarities to wild-type
Pen-2 (i.e., N-termini facing the cytosol and C-termini
facing the lumen), is functionally inactive in mediating
PS1 endoproteolysis and γ-secretase activity [17]. The only
resolution to this paradox is that the middle third of Pen-
2 HP1 is necessary for determining the overall topology of
HP1, but that both the sequence and conformation of the
first fourteen amino acids of the Pen-2 HP1 are essential
for binding to PS1, presumably through interactions with
the “NF” motif within TM4 of PS1, that we and others
determined to be necessary and sufficient for Pen-2 bind-
ing [17, 24, 25].
In summary, we have demonstrated that Pen-2 harbors
a single membrane spanning TMD corresponding to HP2,
with the C-terminus exposed to the lumen. Moreover, we
also demonstrate that the N-terminus of Pen-2 faces the
cytoplasm and by inference, HP1 does not span the
membrane bilayer. Our model is illustrated in Fig. 2f, and
is supported by an elegant report from the laboratory of
Yigong Shi and colleagues [26]wherein the cryo-EM struc-
ture of human γ-secretase at 4.32-Å resolution has
recently been determined. This level of resolution allows
specific assignment of all TMs in the complex and subunit
packing. This structural analysis reveals that Pen-2 har-
bors not two, but three TMDs, the first two of which
traverse the membrane only half-way from the intracellu-
lar side [26]. Thus, the Pen-2 HP1 is partially buried, but
does not traverse, the lipid bilayer of mammalian mem-
branes in a manner similar to “reentrant” loops, defined as
a structural motif that goes only halfway through the
membrane and then turns back to the side from which it
originates and that are a signature of transporters/ion
channels [27]. Moreover, and as was predicted from earlier
mutagenesis and biochemical studies [17, 24], the cyo-EM
studies reveal that N-terminal region of the Pen-2 HP1
associates with TM4 of PS1.
Future studies using mutagenesis and crosslinking ap-
proaches, in combination with in silico modeling and high
resolution X-ray crystallography will be required to define
the molecular basis for Pen-2-mediated autocatalytic
endoproteolysis of PS1 [9] and “activation” of γ-secretase
activity. Clarification of these outstanding issues may lead
to the development of novel strategies to modulate of γ-
secretase activity.
Methods
Cell culture and transfection
Human embryonic kidney (HEK) 293 cells were cultured
in 5 % CO2 at 37 °C in Dulbecco's modified Eagle's
medium (DMEM) containing 100 units/ml penicillin and
100 μg/ml streptomycin sulfate, supplemented with 10 %
(v/v) fetal bovine serum (FBS). Mouse neuroblastoma N2a
cells stably expressing human presenilin 1 (N2aWT.11
cells) and Pen-2 or various TMD1-SREP Pen-2 chimeras
[17] were maintained in 50 % DMEM and 50 % of Opti-
MEM contining 200 ug/ml of hygromycin, 100 units/ml
penicillin and 100 μg/ml streptomycin sulfate, supple-
mented with 5 % FBS. Immortalized Pen-2-deficient
fibroblasts [20] were generously provided by Dr. Bart DeS-
trooper (University of Leuven, Belgium). Pen-2-deficient
cells were transiently transfected using Lipofectamine
2000 (Life Technologies).
Constructs
The cDNAs encoding CT11-tagged Pen-2 and its variants
were described previously [17].
Cell fractionation
Monolayers of HEK293 cells or stable N2a cells were
grown to subconfluence, scraped into 3 ml phosphate-
buffered saline with 5 mM EDTA, and centrifuged at
1000 g for 5 min at 4 °C. The cell pellet from each dish
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was resuspended in 0.4 ml sucrose-containing buffer H
(10 mM Hepes-KOH at pH 7.4, 10 mM KCl, 1.5 mM
MgCl2, 5 mM sodium EDTA, 5 mM sodium EGTA,
250 mM sucrose), passed through a 22-gauge needle
20 times, and centrifuged at 1000 g for 5 min at 4 °C. Each
supernatant was centrifuged at 1.5 × 104 g for 10 min at
4 °C, and the resulting pellet was designated as the P15
membrane fraction.
Protease protection assay
P15 membrane fractions from HEK293 cells or N2a stable
lines expressing PS1, and either wild-type Pen-2 or the
TMD1-SREBP Pen-2 chimeras were treated with protein-
ase K in the presence or absence of 1 % Triton X-100 [18].
After incubation at room temperature for 90 min, the
reactions were terminated by the addition of phenyl-
methylsulfonyl fluoride (PMSF) and subject to centrifuga-
tion at 100,000 x g for 1 h. The pellet fraction was washed
once with Buffer H, resuspended in Laemmli SDS sample
buffer and fractionated by 16.5 % Tris/Tricine SDS/PAGE.
Western blot
Cell lysates and protein fragments were fractionated in
Tris/glycine or 16.5 % Tris/Tricine SDS-PAGE, and trans-
ferred to a nitrocellulose membrane (Schleicher and
Schuell) prior to incubation with appropriate primary and
secondary antisera. Immunoreactive proteins were visual-
ized using an enhanced chemiluminescence detection sys-
tem (ECL; PerkinElmer Life Sciences).
Antibodies
The following antibodies were used for this study and
have been described previously [17] . The PNT-2 antibody
was raised against a peptide corresponding to the NH2-
terminal 26 amino acids of Pen-2 (a generous gift from
Dr. Gopal Thinakaran). The Rb mAb PEN2 is from
Abcam (ab154830). The CT11 antibody specifically recog-
nizes the last 7 amino acids (RFLEERP) of APLP1.
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